Thyroid disease and pulmonary arterial hypertension (PAH) in patients treated with prostacyclin

被引:0
|
作者
Ferris, AM [1 ]
Morse, JH [1 ]
Jacobs, T [1 ]
Rosenzweig, EB [1 ]
Aranoff, GS [1 ]
Barst, RJ [1 ]
机构
[1] Columbia Univ, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2075
引用
收藏
页码:426 / 427
页数:2
相关论文
共 50 条
  • [31] Pulmonary arterial hypertension in patients treated with interferon
    Savale, Laurent
    Chaumais, Marie-Camille
    Sitbon, Olivier
    Humbert, Marc
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (06) : 1851 - 1853
  • [32] Pulmonary arterial hypertension in patients treated with interferon
    Savale, Laurent
    Gunther, Sven
    Chaumais, Marie Camille
    Jais, Xavier
    Sattler, Caroline
    Artaud, Elise
    Montani, David
    Simonneau, Gerald
    Humbert, Marc
    Sitbon, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [33] Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
    Montani, David
    Bergot, Emmanuel
    Guenther, Sven
    Savale, Laurent
    Bergeron, Anne
    Bourdin, Arnaud
    Bouvaist, Helene
    Canuet, Matthieu
    Pison, Christophe
    Macro, Margareth
    Poubeau, Patrice
    Girerd, Barbara
    Natali, Delphine
    Guignabert, Christophe
    Perros, Frederic
    O'Callaghan, Dermot S.
    Jais, Xavier
    Tubert-Bitter, Pascale
    Zalcman, Gerard
    Sitbon, Olivier
    Simonneau, Gerald
    Humbert, Marc
    CIRCULATION, 2012, 125 (17) : 2128 - 2137
  • [34] Pulmonary arterial hypertension in patients treated with interferon
    Savale, Laurent
    Sattler, Caroline
    Guenther, Sven
    Montani, David
    Chaumais, Marie-Camille
    Perrin, Swanny
    Jais, Xavier
    Seferian, Andrei
    Jovan, Roland
    Bulifon, Sophie
    Parent, Florence
    Simonneau, Gerald
    Humbert, Marc
    Sitbon, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (06) : 1627 - 1634
  • [35] Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin
    Idrees, Majdy
    Alnajashi, Khalid
    Abdulhameed, Jasim
    Khan, Atika
    Batubara, Enas
    Alotay, Abdelmajeed
    Fayed, Amal
    Aldammas, Saleh
    Alseif, Moaad
    Alawwad, Husam
    Abusabaa, Yahya
    Almobrad, Mashael
    Kashour, Tarek
    ANNALS OF THORACIC MEDICINE, 2015, 10 (03) : 204 - 211
  • [36] Riociguat in Combination With Prostacyclin Analogs for the Treatment of Pulmonary Arterial Hypertension (PAH): A Subgroup Analysis of the PATENT Studies
    Preston, Ioana
    Hill, Nicholas
    Ghofrani, Hossein Ardeschir
    Hoeper, Marius
    Langleben, David
    Vizza, Carmine Dario
    Nikkho, Sylvia
    Vogtlaender, Kai
    Jansa, Pavel
    CHEST, 2015, 148 (04)
  • [37] Targeted Therapy of pulmonary arterial Hypertension (PAH)
    Klose, H.
    Opitz, C.
    Bremer, H.
    Ewert, R.
    Bonderman, D.
    Rosenkranz, S.
    Seeger, W.
    Schmeisser, A.
    Harbaum, L.
    Buerke, M.
    Ghofrani, H. Ardeschir
    Borst, M. M.
    Leuchte, H. H.
    Lange, T. J.
    Behr, J.
    Ulrich, S.
    Lang, I.
    Olschewski, H.
    Gall, H.
    Kabitz, H. -J.
    Kleber, F. -X.
    Held, M.
    Hoeper, M. M.
    Gruenig, E.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S142 - S150
  • [38] A Literature Review of Pulmonary Arterial Hypertension (PAH)
    Panchal, Ashima
    Panchal, Jigar
    Jain, Sonika
    Dwivedi, Jaya
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2022, 18 (02) : 104 - 114
  • [39] Endothelial dysfunction in pulmonary arterial hypertension (PAH)
    Thambiayya, Kalidasan
    FASEB JOURNAL, 2015, 29
  • [40] Safety and efficacy of sitaxsentan in elderly patients with Pulmonary Arterial Hypertension (PAH)
    Vachiery, J. L.
    Sandoval-Zarate, J.
    Keogh, A.
    Kramer, M. R.
    Barst, R. J.
    Naeije, R.
    EUROPEAN HEART JOURNAL, 2006, 27 : 623 - 623